JASDAQ Listing and Capital Raising Through a Public Offering
First written in FY2018-Q1. 10 of 14 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2025-H1.
The whole theme swung hardest in 2022: 10 of 35 companies on the "Worse" side.
0 other companies' latest entry also says "Raised".
- FY2025-H1RaisedAnnual report
「At a meeting of the board of directors held on 14 April 2025, the company resolved to issue, through a third-party allotment to Nomura Capital Partners Second Investment Limited Partnership, its first series of unsecured convertible bonds with stock acquisition rights. The amount raised was ¥2,000,000,000, with estimated net proceeds of ¥1,967,500,000.」
In addition to previous capital increases and stock acquisition rights, the company expanded its fundraising to include the issuance of unsecured convertible bonds with stock acquisition rights through a third-party allotment, raising approximately ¥2 billion. - FY2023AdvancedAnnual report
「27 July 2022–25 August 2023 2,213,026 shares ¥553.256 million」
Exercise of the stock acquisition rights issued in the rights offering progressed, resulting in the issuance of 2,213,026 shares and an increase of ¥553.256 million each in share capital and capital reserves. - FY2023-Q3RaisedAnnual report
「At a meeting of the board of directors held on 1 June 2023, the company resolved to conduct a rights offering for all shareholders other than the company itself, through the gratis allotment of listed stock acquisition rights without an underwriting commitment, and to issue its fourth series of stock acquisition rights (hereinafter, the “Stock Acquisition Rights”).」
In addition to previous public offerings and exercises of stock acquisition rights, the company resolved to raise funds through the gratis allotment of listed stock acquisition rights to all shareholders. The exercise price was set at ¥500 per share, with an exercise period from 27 July 2023 to 25 August 2023. The intended uses of funds included capital investment in the hydroponic farming business and funds reserved for M&A and other purposes. - FY2021-Q2AdvancedAnnual report
「During the six months ended the second quarter of the current consolidated fiscal year, the company issued 32,100 new shares upon the exercise of stock acquisition rights. As a result, share capital and capital reserves each increased by ¥49.122 million during the period, and at the end of the second quarter of the current consolidated fiscal year, share capital was ¥1.06242 billion and capital reserves were ¥920.12 million.」
The exercise of stock acquisition rights resulted in the issuance of 32,100 shares during the six months ended the second quarter of the current consolidated fiscal year, increasing both share capital and capital reserves by ¥49.122 million. - FY2021-Q1AdvancedAnnual report
「During the first quarter, stock acquisition rights attached to bonds with stock acquisition rights containing an adjustment clause for the exercise price and other instruments were exercised as follows.」
During the first quarter, 301 stock acquisition rights were exercised, 30,100 shares were issued and ¥95.722 million was raised. Cumulative totals were 4,000 rights, 400,000 shares and ¥1.116083 billion. - FY2020-Q3AdvancedAnnual report
「During the third quarter, share acquisition rights relating to bonds with share acquisition rights and other instruments with an exercise price adjustment clause were exercised as follows.」
During the third quarter, 404 stock acquisition rights were exercised, 40,400 shares were issued and ¥101.197 million was raised. Cumulative issuance totaled 219,400 shares, and cumulative proceeds were ¥578.526 million. - FY2020-Q2AdvancedAnnual report
「During the second quarter, the stock acquisition rights related to stock acquisition rights, etc. with adjustment provisions for the exercise price were exercised as follows.」
During the second quarter, 720 stock acquisition rights were exercised, 72,000 shares were issued and ¥183.513 million was raised. Cumulative totals were 179,000 shares and ¥477.328 million raised. - FY2019-Q3AdvancedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, the company issued 116,300 new shares upon the exercise of stock acquisition rights. As a result, share capital and capital reserves each increased by ¥102.017 million during the period, and at the end of the third quarter of the current consolidated fiscal year, share capital was ¥562.775 million and capital reserves were ¥420.475 million.」
The exercise of stock acquisition rights resulted in the cumulative issuance of 116,300 shares and increased both share capital and capital reserves by ¥102.017 million. - FY2019-Q2AdvancedAnnual report
「During the second quarter, the stock acquisition rights related to stock acquisition rights, etc. with adjustment provisions for the exercise price were exercised as follows.」
A total of 517 of the third series of stock acquisition rights were exercised, 51,700 shares were delivered and ¥145 million was raised. Cumulatively, 99,700 new shares were issued, increasing share capital and capital reserves by ¥85.846 million each. - FY2019-Q1RaisedAnnual report
「At a meeting of the board of directors held on 14 December 2018, the company resolved to issue, through a third-party allotment to SMBC Nikko Securities Inc. (hereinafter, “SMBC Nikko Securities”) as the intended allottee, its third series of stock acquisition rights with provisions for adjustment of the exercise price (hereinafter, the “Stock Acquisition Rights”), and to enter into a facility agreement (hereinafter, the “Facility Agreement”) after the notification relating to the Stock Acquisition Rights under the Financial Instruments and Exchange Act became effective. Payment of the total issue price of the Stock Acquisition Rights was completed on 7 January 2019.」
In addition to previous public offerings and exercises of stock acquisition rights, the company expanded its fundraising through the issuance of 4,000 stock acquisition rights representing 400,000 potential shares, raising approximately ¥1.6456 billion net of expenses. - FY2018AdvancedAnnual report
「The issuance of 120,800 new shares through the exercise of stock acquisition rights increased both share capital and capital reserves by ¥31.7 million.」
Following the public offering and third-party allotment, the company made an additional issuance through the exercise of stock acquisition rights, increasing share capital and capital reserves. - FY2018-Q3AdvancedAnnual report
「In addition, the issuance of 75,200 new shares through the exercise of stock acquisition rights increased both share capital and capital surplus by ¥19.2 million. As a result, at the end of the third quarter of the current consolidated fiscal year, share capital was ¥448.258 million and capital surplus was ¥305.958 million.」
Following the public offering and third-party allotment at the time of listing, the company issued 75,200 shares through the exercise of stock acquisition rights, with corresponding additional increases in share capital and capital surplus. - FY2018-Q2AdvancedAnnual report
「In addition, a third-party allotment, related to the secondary offering through an over-allotment, with a payment date of 26 December 2017 increased the number of shares issued by 69,300 and increased both share capital and capital surplus by ¥23.908 million.」
Following the public offering at the time of listing, the company conducted a third-party allotment, resulting in additional increases in the number of shares, share capital and capital surplus. - FY2018-Q1First statedAnnual report
「In connection with its listing, the company conducted a public offering with a payment date of 27 November 2017, increasing the number of shares issued by 320,000 and increasing both share capital and capital surplus by ¥110.4 million.」
In connection with its JASDAQ listing on 28 November 2017, the company conducted a public offering and stated that the proceeds would be used for investments and loans to 2 consolidated subsidiaries and for working capital.